PAI-1 plays a central role in the regulation of plasmin formation by inhibiting plasminogen activators (i.e., urokinase-plasminogen activator and tissue type plasminogen activator) and has been implicated in pathological angiogenesis in cancer (60) and in the eye (61). The gene discussed is PLG; the disease is cancer.